Mr. Ted Breck serves as Managing Director at TPG Biotech. Mr. Breck leads TPG's Life Sciences structured investments for mid and late-stage pharma pipeline assets, drug launches and drug royalty monetizations. Previously, Mr. Breck led the effort at TPG-Axon Capital for three years where they invested over $1.3 billion in such structured financings. Prior to joining TPG in 2005, Mr. Breck had nearly two decades of experience in healthcare investment banking at Lehman Brothers in New York and subsequently, San Francisco, where he led the firm's West Coast Life Sciences business in financing and merger and acquisition transactions. Mr. Breck received his B.A. at the University of California at Berkeley. Mr. Breck is a member of the Advisory Council of the J. David Gladstone Institutes, an independent, non-profit biomedical research organization affiliated with the University of California, San Francisco.